Skip to main content

Table 5 Associations of two polymorphism models in the CD160 gene with HT before and after adjusting for confounders

From: Associations between CD160 polymorphisms and autoimmune thyroid disease: a case-control study

Comparison models Unadjusted estimates Adjusted estimatesa
OR (95%CI) P values OR (95%CI) P values
rs744877
 Allele Model 0.95 (0.79–1.14) 0.585 0.95 (0.79–1.16) 0.632
 Dominant Model 1.06 (0.82–1.37) 0.664 1.07 (0.82–1.40) 0.615
 Recessive model 1.09 (0.74–1.61) 0.669 1.11 (0.73–1.67) 0.629
 Homozygous model 1.01 (0.67–1.52) 0.972 1.04 (0.68–1.60) 0.860
 Additive model 0.86 (0.67–1.11) 0.244 0.86 (0.66–1.12) 0.262
rs3766526
 Allele Model 1.06 (0.85–1.32) 0.631 1.09 (0.86–1.39) 0.457
 Dominant Model 0.89 (0.69–1.13) 0.325 0.89 (0.69–1.14) 0.354
 Recessive model 1.12 (0.55–2.27) 0.750 1.46 (0.69–3.09) 0.322
 Homozygous model 1.14 (0.56–2.31) 0.719 1.45 (0.69–3.08) 0.328
 Additive model 1.05 (0.81–1.37) 0.713 1.04 (0.79–1.37) 0.785
  1. HT Hashimoto’s thyroiditis, OR Odds ratio, 95%CI 95% confidence interval; a Age and gender were adjusted in the multivariate logistic regression analyses